Page 107 - 《中国药房》2022年12期

diotherapy in non-small cell lung cancer：a case report[J]. [40] VAISHAMPAYAN U，PARCHMENT R E，JASTI B R，
Medicine（Baltimore），2020，99（17）：e19878. et al. Taxanes：an overview of the pharmacokinetics and
[28] SPIGEL D R，HAINSWORTH J D，YARDLEY D A，et al. pharmacodynamics[J]. Urology，1999，54（6A Suppl）：
Tracheoesophageal fistula formation in patients with lung 22-29.
cancer treated with chemoradiation and bevacizumab[J]. J [41] KHAROFA J，CHOONG N，WANG D，et al. Continuous-
Clin Oncol，2010，28（1）：43-48. course reirradiation with concurrent carboplatin and
[29] GOODGAME B，VEERAMACHANENI N，PATTERSON paclitaxel for locally recurrent，nonmetastatic squamous
A，et al. Tracheo-esophageal fistula with bevacizumab af- cell carcinoma of the head-and-neck[J]. Int J Radiat Oncol
ter mediastinal radiation[J]. J Thorac Oncol，2008，3（9）： Biol Phys，2012，83（2）：690-695.
1080-1081. [42] CHENG N N，LIU Y，ZHAO G Q，et al. Phase Ⅰ trial of
[30] YAMADA H，SHIGEMORI W，RYUJIN Y，et al. Tracheal intensity-modulated hyperfractionated radiotherapy boost
fistula associated with bevacizumab 20 months after me- with concurrent chemotherapy immediately following
diastinal radiation[J]. BMJ Case Rep，2010，2010：bcr082- standard chemoradiotherapy in patients primarily with ad-
0103284. vanced intra-thoracic/cervical esophageal squamous cell
[31] SOCINSKI M A，STINCHCOMBE T E，MOORE D T，
carcinomas[J]. Int J Radiat Oncol Biol Phys，2020，106
et al. Incorporating bevacizumab and erlotinib in the com- （2）：340-348.
bined-modality treatment of stage Ⅲ non-small-cell lung
[43] LEE C C，YEO C M，NG W K，et al. T4 cervical esopha-
cancer：results of a phase Ⅰ/Ⅱ trial[J]. J Clin Oncol，
geal cancer cured with modern chemoradiotherapy：a case
2012，30（32）：3953-3959. report[J]. World J Clin Cases，2020，8（10）：1950-1957.
[32] NISHINARI Y，KASHIWABA M，UMEMURA A，et al.
[44] CHANG J Y，VERMA V，LI M，et al. Proton beam radio-
Pulmonary hilar lymph node metastasis of breast cancer therapy and concurrent chemotherapy for unresectable
induced bronchopleural fistula and superior vena cava syn-
stage Ⅲ non-small cell lung cancer：final results of a
drome[J]. Am J Case Rep，2014，15：492-495.
phase 2 study[J]. JAMA Oncol，2017，3（8）：e172032.
[33] MACHUZAK M S，SANTACRUZ J F，JABER W，et al.
Malignant tracheal-mediastinal-parenchymal-pleural fistu- [45] ABUGROUN A，AHMED F，SINGH N，et al. Late onset
chemo/radiation induced tracheoesophageal fistula in
la after chemoradiation plus bevacizumab：management
with a Y-silicone stent inside a metallic covered stent[J]. J squamous cell cancer of the lung[J]. World J Oncol，2017，
8（5）：171-173.
Bronchology Interv Pulmonol，2015，22（1）：85-89.
[46] MOTOYAMA S，HOSONO Y，MARUYAMA K，et al. A
[34] YAMASAKI M，DAIDO W，FUNAISHI K，et al. Ni-
volumab therapy for lung cancer with tracheo-parenchy- case of thoracic esophageal cancer with invasion of the
main Bronchus in which long-term survival with high
mal fistula：a case report[J]. Medicine（Baltimore），2018，
97（50）：e13739. quality of life was achieved through chemoradiotherapy，
[35] BALAZS A，KUPCSULIK P K，GALAMBOS Z. Eso- esophageal bypass and then additional chemotherapy[J].
phagorespiratory fistulas of tumorous origin：non-opera- Gan To Kagaku Ryoho，2007，34（13）：2283-2285.
tive management of 264 cases in a 20-year period[J]. Eur [47] SOHN J H，CHOI H J，CHANG J，et al. A phase Ⅱ trial
J Cardio Thorac Surg，2008，34（5）：1103-1107. of fractionated irinotecan plus carboplatin for previously
[36] 张轶雯，方罗，钟里科，等.贝伐珠单抗在我院抗肿瘤治疗 untreated extensive-disease small cell lung cancer[J].
中的应用分析[J].中国药房，2018，29（16）：2252-2256. Lung Cancer，2006，54（3）：365-370.
[37] HARDIANSYAH D，NG C M. Minimal physiologically- [48] OZEKI T，ASANO M，FUJIMOTO N，et al. Esophago-
based pharmacokinetic model to investigate the effect of bronchial fistula in a patient with squamous cell carcino-
pH dependent FcRn affinity and the endothelial endocyto- ma of the lung：a case report[J]. Case Rep Oncol，2017，10
sis on the pharmacokinetics of anti-VEGF humanized （2）：553-557.
IgG1 antibody in cynomolgus monkey[J]. Eur J Pharm [49] REED M F，MATHISEN D J. Tracheoesophageal fistu-
Sci，2018，125：130-141. la[J]. Chest Surg Clin N Am，2003，13（2）：271-289.
[38] XU L，ZUCH C L，LIN Y S，et al. Pharmacokinetics and [50] JIAO D C，YAO Y，ZHANG Q H，et al. Effectiveness and
safety of bevacizumab administered in combination with safety of a newly designed partially covered tracheal me-
cisplatin and paclitaxel in cynomolgus monkeys[J]. Can- tallic Y-shaped stent for the treatment of high cervical ga-
cer Chemother Pharmacol，2008，61（4）：607-614. stro-tracheal or tracheo-esophageal fistula：a retrospective
[39] RAHMAN A，KORZEKWA K R，GROGAN J，et al. Se- observational study[J]. Medicine（Baltimore），2021，100
lective biotransformation of taxol to 6 α-hydroxytaxol by （11）：e25132.
human cytochrome P450 2C8[J]. Cancer Res，1994，54 （收稿日期：2021-11-09 修回日期：2022-03-30）
（21）：5543-5546. （编辑：孙 冰）

中国药房 2022年第33卷第12期 China Pharmacy 2022 Vol. 33 No. 12 ·1505 ·